While the interaction between tumor-associated SCs and NK cells has not yet been documented, SC-derived TGF-β, PgE2, IL-6, and other molecules are known to control the activation and function of NK cells, suggesting a likely crosstalk between SCs and NK cells in the tumor environment [660]. The gene discussed is IL6; the disease is neoplasm.